4//SEC Filing
LaBelle Curt H 4
Accession 0001638599-19-000021
CIK 0001682639other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:29 PM ET
Size
14.6 KB
Accession
0001638599-19-000021
Insider Transaction Report
Form 4
EYENOVIA, INC.EYEN
LaBelle Curt H
Director10% Owner
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-01-02−140,000→ 140,000 total(indirect: By Private Medical Equity, Inc.)Exercise: $1.24From: 2015-03-23Exp: 2025-03-23→ Common Stock (140,000 underlying) - Exercise/Conversion
Common Stock, par value $.0001
2019-01-02$1.24/sh+140,000$173,600→ 606,667 total(indirect: By Private Medical Equity, Inc.)
Holdings
- 10,000
Common Stock, par value $.0001
- 40,000
Stock Option (right to buy)
Exercise: $1.24From: 2015-03-02Exp: 2025-03-02→ Common Stock (40,000 underlying) - 133,334
Stock Option (right to buy)
Exercise: $1.95Exp: 2027-07-07→ Common Stock (133,334 underlying) - 453,333(indirect: By LLC)
Common Stock, par value $.0001
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]The option became exercisable as to 3,704 shares on August 7, 2017, and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.
Issuer
EYENOVIA, INC.
CIK 0001682639
Entity typeother
Related Parties
1- filerCIK 0001396235
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:29 PM ET
- Size
- 14.6 KB